Expanded Access Protocol Thymus Transplantation

Clinical trial NCT02274662 · COMPLETED

Trial details

NCT number: NCT02274662
Sponsor: Sumitomo Pharma Switzerland GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Poor Thymic Function Immunodeficiency Athymia Immunoreconstitution Thymus Transplantation Low T Cell Numbers

Start date: 2014-08-01
Primary completion: 2023-08-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.